法律意见书 北京观韬（南京）律师事务所 关于南京红太阳股份有限公司 2025 年第二次临时股东大会之 法律意见书 观韬宁证红太阳字（2025）第 3 号 致：南京红太阳股份有限公司 北京观韬（南京）律师事务所（以下简称"本所"）接受南京红太阳股份有 限公司（以下简称"公司"）的委托，指派肖志强律师、陶丽霞律师（以下简称 "本所律师"）出席了公司 2025 年第二次临时股东大会（以下简称"本次会议"）， 对本次会议进行见证并发表法律意见。 一、本次会议的召集、召开程序 （一）本次会议的召集程序 1 法律意见书 1. 2025 年 8 月 27 日，公司第十届董事会第五次会议审议通过了《关于提请 召开 2025 年第二次临时股东大会的议案》。 2. 2025 年 8 月 29 日，公司在《中国证券报》《证券时报》和巨潮资讯网发 布了《关于召开 2025 年第二次临时股东大会的通知》（以下简称"《通知》"）， 通知载明会议现场采取现场投票与网络投票相结合的方式，并公告了会议召开的 时间、地点、股权登记日、出席对象、会议审议事项、现场会议登记方法、网络 投票时间及程序等内容。 为出具本法律意见书，本所律师审查了公司本 ...

证券代码：000525 证券简称：红太阳 公告编号：2025－044 南京红太阳股份有限公司 — 1 — 求公司承担因此产生的虚假陈述赔偿责任。），双方确定损失金额后， 部分中小投资者按照重整计划选择了"现金+股票"的债权清偿方案， 管理人根据南京市中级人民法院（以下简称"南京中院"）作出的已生 效法律文书，向南京中院申请通过管理人专用账户向 9 名中小投资者 指定证券账户合计过户偿债股票 169,152 股。 关于向部分中小投资者指定证券账户过户重整转增股票情 况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、前期过户情况 2024 年 11 月 1 日，南京市中级人民法院裁定批准南京红太阳股 份有限公司重整计划（以下简称"重整计划"）。公司为执行重整计划 实施资本公积金转增股本，本次转增的股票中共有 525,371,410 股登 记在管理人开立的"南京红太阳股份有限公司破产企业财产处置专用 账户"（以下简称"管理人专用账户"），并由管理人根据重整计划的 规定分配。 2024 年 11 月 27 日，管理人向重整投资人指定证券账户合计过 户 30 ...

Core Insights - The glyphosate concept sector saw an increase of 0.94%, ranking third among concept sectors, with 13 stocks rising, including Li Er Chemical, Jiangshan Co., and Yangnong Chemical, which rose by 6.17%, 2.70%, and 2.10% respectively [1] - The sector experienced a net inflow of 0.20 billion yuan from main funds, with Li Er Chemical leading the inflow at 13.30 million yuan [1] Market Performance - The top-performing concept sectors included soybeans at 1.02%, and the glyphosate sector at 0.94%, while sectors like Tonghuashun Fruit Index and AI PC saw declines of -4.09% and -4.01% respectively [1] - The main funds' net inflow rates for Jiangtian Chemical, Hebang Biological, and Ando Mai A were 10.43%, 6.41%, and 3.60% respectively [2] Stock Performance - Li Er Chemical led the glyphosate sector with a daily increase of 6.17% and a turnover rate of 5.86%, with a net inflow of 13.30 million yuan [2] - Jiangtian Chemical and Hebang Biological also showed positive performance with increases of 0.67% and 0.00% respectively, and significant net inflows of 7.54 million yuan and 10.25 million yuan [2][3] - Stocks such as Nuobing and Taihe Co. experienced declines of -0.85% and -0.58% respectively, indicating some volatility within the sector [3]

Group 1 - The regulatory environment for A-shares has tightened significantly since the introduction of new delisting rules, leading to a more pronounced survival of the fittest dynamic in the market, with 159 companies being designated as ST (Special Treatment) this year [1] - The majority of newly designated ST companies are from the main board, contributing 111 out of the total, while the ChiNext and Sci-Tech Innovation Board account for 45, and the Beijing Stock Exchange has its first three ST companies [1][3] - The new regulations have implemented a dual-stranglehold on problematic companies through quantitative financial indicators and detailed regulatory standards [1] Group 2 - The most prominent issue leading to ST designations is revenue-related, with 54 companies being designated due to their 2024 revenue falling below 300 million yuan, primarily occurring around April when annual reports were disclosed [3] - Other reasons for ST designations include financial report falsifications, negative net assets, and bankruptcy, with 17 companies flagged for false financial reporting [6][7] - The computer and pharmaceutical industries have the highest number of ST companies, reflecting the high competition and rapid changes in these sectors, with 18 and 15 companies respectively [10][11] Group 3 - Despite the increasing number of ST companies, 46 companies have successfully removed their ST status this year through acquisitions and capital injections, meeting regulatory requirements [14] - Notable companies that have successfully "un-capped" include Huijin Co., Zhaojin Gold, and Tongzhou Electronics, among others [14] - The case of Shengtun Mining is highlighted, which achieved a revenue of 13.8 billion yuan in the first half of the year, despite being flagged for false reporting in previous years [15][16]

Group 1 - On September 24, Hongyang's block trade involved 600,000 shares with a transaction value of 3.348 million yuan, accounting for 4.04% of the total transaction volume for the day [1] - The transaction price was 5.58 yuan, which represents a 10% discount compared to the market closing price of 6.2 yuan [1] Group 2 - The buyer was Dongxing Securities Co., Ltd., and the seller was CITIC Securities Co., Ltd. [2] - The transaction occurred in Chengdu, Sichuan Province, and involved the securities business departments of both firms [2]

证券代码：000525 证券简称：红太阳 公告编号：2025－043 南京红太阳股份有限公司 监事会关于公司 2025 年限制性股票激励计划激励对象名单 的公示情况说明及核查意见 本公司及监事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 南京红太阳股份有限公司（以下简称"公司"）于 2025 年 9 月 12 日召开第十届董事会第六次会议和第十届监事会第四次会议，审议通 过了《关于<公司 2025 年限制性股票激励计划（草案）>及摘要的议 案》等相关议案。 公司根据《公司法》《证券法》《上市公司股权激励管理办法》 （以下简称 "《管理办法》"）等法律、法规和规范性文件以及《公 司章程》的相关规定，对《公司 2025 年限制性股票激励计划（草案）》 （以下简称"本次激励计划"或"激励计划"）中所确定的激励对象名单 在公司内部进行了公示。公司监事会结合公示情况对激励对象名单进 行了核查，相关公示情况说明及核查意见如下： 一、公示情况及核查方式 — 1 — 资源部门和业务部门就相关问题向员工进行了解释说明；针对上述名 单中激励对象资格的合法合规性，公司监事会未收到相关异议反馈 ...

Company Overview - Hongyang Sun is located in Nanjing, Jiangsu Province, established on June 13, 1991, and listed on October 28, 1993. The company specializes in the research and production of new environmentally friendly pesticides, with pesticide sales accounting for 96.95% of its main business revenue [1][2]. Stock Performance - On September 22, Hongyang Sun's stock price decreased by 2.13%, reaching 6.42 CNY per share, with a trading volume of 66.64 million CNY and a turnover rate of 1.04%. The total market capitalization is 8.33 billion CNY [1]. - Year-to-date, the stock price has increased by 7.54%, but it has seen declines of 3.17% over the last five trading days, 8.02% over the last 20 days, and 13.48% over the last 60 days [1]. Capital Flow - There was a net outflow of 11.49 million CNY from main funds, with no large orders bought and 3.54 million CNY sold, accounting for 5.31%. Large orders bought totaled 10.96 million CNY (16.45%), while large orders sold reached 18.92 million CNY (28.39%) [1]. Financial Performance - For the period from January to June 2025, Hongyang Sun reported a revenue of 1.46 billion CNY, a year-on-year decrease of 11.08%. The net profit attributable to the parent company was -208 million CNY, a significant decline of 1081.73% [2]. - Since its A-share listing, the company has distributed a total of 1.146 billion CNY in dividends, with no dividends paid in the last three years [2]. Shareholder Information - As of August 29, the number of shareholders for Hongyang Sun was 47,400, an increase of 3.92% from the previous period. The average number of circulating shares per person is 20,892, which is a decrease of 3.77% [2].

Core Viewpoint - Nanjing Hongtaiyang Co., Ltd. has received approval from the Qujing High-tech Industrial Development Zone Management Committee for its 2025 restricted stock incentive plan, which is pending shareholder approval for implementation [1][2]. Group 1 - The company held its sixth meeting of the tenth board of directors and the fourth meeting of the tenth supervisory board on September 12, 2025, where the draft of the 2025 restricted stock incentive plan was approved [1]. - The Qujing High-tech Zone Management Committee has issued a formal approval for the company's implementation of the restricted stock incentive plan [1]. - The company will proceed with the plan in compliance with relevant laws and regulations, including the Company Law and Securities Law, and will ensure timely information disclosure [2].

Group 1 - The company announced that it will hold the sixth meeting of the tenth board of directors and the fourth meeting of the tenth supervisory board on September 12, 2025 [1] - The company received approval from the Qujing High-tech Industrial Development Zone Management Committee for the implementation of the 2025 restricted stock incentive plan [1] - The approval from the management committee indicates a positive step towards the company's incentive strategy [1]

南京红太阳股份有限公司（以下简称"公司"）于 2025 年 9 月 12 日召开第十届董事会第六次会议和第十届监事会第四次会议，审议通 过了《关于<公司 2025 年限制性股票激励计划（草案）>及摘要的议 案》等相关议案，具体内容详见公司于 2025 年 9 月 13 日在《中国证 券报》《证券时报》及巨潮资讯网披露的相关公告。 近日，公司收到曲靖高新技术产业开发区管理委员（以下简称"曲 靖高新区管委会"）出具的《关于同意南京红太阳股份有限公司实施 限制性股票激励计划的批复》（曲高新复〔2025〕6 号），曲靖高新 区管委会原则同意公司实施 2025 年限制性股票激励计划。 证券代码：000525 证券简称：红太阳 公告编号：2025－042 南京红太阳股份有限公司 关于公司 2025 年限制性股票激励计划获得曲靖高新技术产 业开发区管理委员会批复的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 南京红太阳股份有限公司 董 事 会 2025年9月18日 公司 2025 年限制性股票激励计划相关事宜尚需提交公司股东大 会审议通过后方可实施。公司将严格按照《 ...